Mali Weisz-Gana

6 Weizmann Street
Tel Aviv, TA 64239, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Effect of genetic factors on [18F]FDG PET metabolic phenotypes in dementia with Lewy bodies.

Effect of genetic factors on [18F]FDG PET metabolic phenotypes in dementia with Lewy bodies.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 26, 2026

Analysis of α-synuclein seed amplification assay in carriers of GBA1 and LRRK2 pathogenic variants.

Analysis of α-synuclein seed amplification assay in carriers of GBA1 and LRRK2 pathogenic variants.

Journal: Journal of Parkinson's disease

Published: January 23, 2026

The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers.

The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers.

Journal: Journal of Parkinson's disease

Published: February 20, 2025

P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset.

P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset.

Journal: Journal of Parkinson's disease

Published: February 17, 2025

A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson's disease.

A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson's disease.

Journal: Frontiers in molecular neuroscience

Published: May 12, 2024

TMEM16F regulates pathologic α-synuclein secretion and spread in cellular and mouse models of Parkinson's disease.

TMEM16F regulates pathologic α-synuclein secretion and spread in cellular and mouse models of Parkinson's disease.

Journal: Aging cell

Published: April 15, 2024

Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies.

Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 03, 2024

Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.

Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.

Journal: NPJ Parkinson's disease

Published: March 21, 2024

White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (gCJD).

White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (gCJD).

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: March 10, 2024

MAPT Locus in Parkinson's Disease Patients of Ashkenazi Origin: A Stratified Analysis.

MAPT Locus in Parkinson's Disease Patients of Ashkenazi Origin: A Stratified Analysis.

Journal: Genes

Published: November 13, 2023

Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease.

Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease.

Journal: Parkinsonism & related disorders

Published: September 22, 2023

Validity of the Short Weekly Calendar Planning Activity in patients with Parkinson disease and nonmanifesting LRRK2 and GBA carriers.

Validity of the Short Weekly Calendar Planning Activity in patients with Parkinson disease and nonmanifesting LRRK2 and GBA carriers.

Journal: European journal of neurology

Published: August 21, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026